Covid-19
European Journal of Neurology:
Neurological complications
associated with acute coronavirus disease 2019 (COVID-19) are well described.
Now, increasing evidence suggests that symptoms may persist even beyond
4–12 weeks after disease onset
Frequent neurological, cognitive
and neuropsychiatric long-term symptoms after COVID-19 include b...
American Journal of Obstetrics and Gynecology:
Key findings
Vaccine-generated antibodies were
present in umbilical cord blood and breastmilk after maternal vaccination.
Pregnant and lactating women
elicited comparable vaccine-induced humoral immune responses with nonpregnant
controls and generated higher antibody titers than those o...
JAMA Network:
SARS-CoV-2 continues to infect more
than 22 million patients per week and globally causes more than 65 000 deaths
per week as of January 31, 2022.
Although aspirin has not been shown
to reduce major adverse cardiovascular or pulmonary events in symptomatic
outpatients with COVID-19, several observational studies have fou...
American College of Physicians (ACP) Journals: Annals of Internal
Medicine
Nirmatrelvir–ritonavir (NMV/r) is use in high-risk patients with
mild to moderate COVID-19 who are likely to be receiving other medications. NMV/r
administered within three days of symptom onset reduced the risk of COVID-19
related hospitalization and death from a...
Coronavirus (COVID-19) Vaccine Update:
Take Home Message:
A single booster dose of the Pfizer
COVID-19 vaccine can be given to 5- to 11-year-olds to provide continued
protection against COVID-19., the U.S. Food and Drug Administration announced.
The third shot can be given at
least five months after healthy children complete the two...
European Heart Journal:
Emerging as a new epidemic, long COVID or post-acute sequelae
of coronavirus disease 2019 (COVID-19), a condition characterized by the
persistence of COVID-19 symptoms beyond 3 months. The long-term impact of COVID-19 on cardiovascular (CV) health and
mortality is also emerging as a major global concern.
Definit...
European Heart Journal:
Worldwide, survivors of COVID-19
now exceed hundreds of millions, with some reporting incomplete recovery months
beyond the acute illness, a condition commonly referred to as long COVID.
Persistent symptoms of breathlessness, chest pain, fatigue, headaches, brain
fog, and palpitations are a constant reminder of th...
American Academy of Neurology (AAN) Journal:
Novel coronavirus disease
(COVID-19) has been suggested to not only affect health during the acute phase
of the SARS-CoV-2 infection, but some manifestations have been consistently
reported also after the recovery. Such phenomenon has been named “long-COVID”
or “post-acute COVID-19”.
These...
The human
pancreas is a target of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2). New-onset hyperglycaemia and insulin resistance have been
reported in patients with coronavirus disease-2019 (Covid-19) without history
of diabetes.
However,
it is unclear whether such metabolic alterations are transient or whether
individu...
American Academy of Pediatric Journal:
TAKE-HOME MESSAGE
This retrospective cohort study
looked at the association between asthma and SARS-CoV-2 infection risk in
children aged 5 to 17 years. Children who had asthma were more likely to be
tested for SARS-CoV-2 infection than those without asthma.
However, the infection rates among...
The
FDA has authorized use of the nirmatrelvir/ritonavir, for the treatment of mild
to moderate COVID-19. Studies have indicated that it is 88% effective at
preventing hospitalization and death from COVID-19.
Criteria
for Prescribing
To prescribe nirmatrelvir/ritonavir,
prescribers should confirm that the following criteria have been...
Urinary
tract infections (UTIs) represent a common pathology among female patients,
leading to overprescribing antibiotics, globally. The emergence of the COVID-19
pandemic has dramatically increased the incidence of this particular viral
pneumonia with secondary bacterial superinfection, resulting in continuous
therapeutic or prophylactic...
